Drug information for ONTAK

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
VIAL	150UG/ML	Prescription		DENILEUKIN DIFTITOX	denileukin diftitox	EISAI INC	103767 2011-09-02 Label 2008-10-28 Label 2008-10-23 Letter 2004-03-25 Review 2004-03-25 Letter 2004-03-25 Label

Drug Adverse Effects information for ONTAK

Role code	Indications	Reaction	# Reports
PS	ANTICOAGULANT THERAPY	CELLULITIS	2
PS	ANTICOAGULANT THERAPY	MENTAL STATUS CHANGES	2
PS	ATRIAL FIBRILLATION	CELLULITIS	1
PS	ATRIAL FIBRILLATION	MENTAL STATUS CHANGES	1
PS	CARDIAC DISORDER	CELLULITIS	1
PS	CARDIAC DISORDER	MENTAL STATUS CHANGES	1
PS	CONSTIPATION	CELLULITIS	2
PS	CONSTIPATION	MENTAL STATUS CHANGES	2
PS	DIABETES MELLITUS	CELLULITIS	1
PS	DIABETES MELLITUS	MENTAL STATUS CHANGES	1
PS	ECZEMA	CELLULITIS	2
PS	ECZEMA	MENTAL STATUS CHANGES	2
PS	FATIGUE	CELLULITIS	2
PS	FATIGUE	MENTAL STATUS CHANGES	2
PS	HYPERTENSION	CELLULITIS	6
PS	HYPERTENSION	MENTAL STATUS CHANGES	6
PS	HYPOKALAEMIA	CELLULITIS	2
PS	HYPOKALAEMIA	MENTAL STATUS CHANGES	2
PS	OSTEOARTHRITIS	CELLULITIS	2
PS	OSTEOARTHRITIS	MENTAL STATUS CHANGES	2
PS	PREMEDICATION	CELLULITIS	4
PS	PREMEDICATION	MENTAL STATUS CHANGES	4
PS	VITAMIN SUPPLEMENTATION	CELLULITIS	2
PS	VITAMIN SUPPLEMENTATION	MENTAL STATUS CHANGES	2

Ads by Google